共 50 条
- [35] Concurrent JAK2-Positive Myeloproliferative Disorder and Chronic Myelogenous Leukemia: A Novel Entity? A Case Report With Review of the Literature JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2019, 7
- [37] MK-0457 is a novel aurora kinaseand janus kinase 2 inhibitor with activity in transformed JAK2-positive myeloproliferative disease HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 243 - 244